Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains

Dow Jones

Yesterday

DJ Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Incyte Corp. $(INCY)$ rallied 1.36% to $129.72 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.32% to 7,677.28 and the Dow Jones Industrial Average rising 0.30% to 53,577.40.

This was the stock's third consecutive day of gains.

Incyte Corp. closed 2.17% below its 52-week high of $132.60, which the company achieved on July 28th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 1.72% to $240.08, Bio-Techne Corp. (TECH) fell 0.08% to $72.33, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 1.61% to $66.12.

Trading volume (1.2 M) remained 666,943 below its 50-day average volume of 1.8 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketd.com/news/2662975229"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2662975229\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2662975229?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 05:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662975229","market":"hk","top_or_hot":-1,"title":"Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Incyte Corp. <a href=\"https://laohu8.com/S/INCY\">$(INCY)$</a> rallied 1.36% to $129.72 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Incyte Corp. closed 2.17% below its 52-week high of $132.60, which the company achieved on July 28th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> rose 1.72% to $240.08, <a href=\"https://laohu8.com/S/TECH\">Bio-Techne</a> Corp. (TECH) fell 0.08% to $72.33, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> rose 1.61% to $66.12. \n</p>\n<p>\n     Trading volume (1.2 M) remained 666,943 below its 50-day average volume of 1.8 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Incyte Corp. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIncyte Corp. Stock Underperforms Tuesday When Compared to Competitors Despite Daily Gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-08-26 05:03</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Incyte Corp. <a href=\"https://laohu8.com/S/INCY\">$(INCY)$</a> rallied 1.36% to $129.72 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Incyte Corp. closed 2.17% below its 52-week high of $132.60, which the company achieved on July 28th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/ALNY\">$(ALNY)$</a> rose 1.72% to $240.08, <a href=\"https://laohu8.com/S/TECH\">Bio-Techne</a> Corp. (TECH) fell 0.08% to $72.33, and BioMarin Pharmaceutical Inc. <a href=\"https://laohu8.com/S/BMRN\">$(BMRN)$</a> rose 1.61% to $66.12. \n</p>\n<p>\n     Trading volume (1.2 M) remained 666,943 below its 50-day average volume of 1.8 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INCY","symbol_name":"因塞特医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2662975229","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2662975229","pubTimestamp":1787691780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Incyte Corp.  rallied 1.36% to $129.72 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40.This was the stock's third consecutive day of gains.Incyte Corp. closed 2.17% below its 52-week high of $132.60, which the company achieved on July 28th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc.  rose 1.72% to $240.08, Bio-Techne Corp.  fell 0.08% to $72.33, and BioMarin Pharmaceutical Inc.  rose 1.61% to $66.12.Trading volume  remained 666,943 below its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"INCY":"因塞特医疗"},"translate_title":"尽管每日上涨，但与竞争对手相比，Incyte Corp. 股票周二表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INCY":1.5},"content_text":"DJ Incyte Corp. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Incyte Corp. $(INCY)$ rallied 1.36% to $129.72 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.32% to 7,677.28 and the Dow Jones Industrial Average  rising 0.30% to 53,577.40. \n\n\n     This was the stock's third consecutive day of gains. \n\n\n     Incyte Corp. closed 2.17% below its 52-week high of $132.60, which the company achieved on July 28th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Alnylam Pharmaceuticals Inc. $(ALNY)$ rose 1.72% to $240.08, Bio-Techne Corp. (TECH) fell 0.08% to $72.33, and BioMarin Pharmaceutical Inc. $(BMRN)$ rose 1.61% to $66.12. \n\n\n     Trading volume (1.2 M) remained 666,943 below its 50-day average volume of 1.8 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled August 25, 2026.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}